NCT03445455

Brief Summary

High Tidal volume is one of the main mechanisms that lead to lung injuries under mechanical ventilation (ventilator induced lung injury: VILI). It could also induce lung damage during spontaneous or assisted ventilation (patient-self inflicted lung injury: P-SILI). Different non invasive oxygenation devices are available to deliver oxygen during acute hypoxemic respiratory failure: high concentration mask, high flow nasal canula and non-invasive ventilation (with bucco-nasal mask or helmet). The investigators hypothesized that the device may influence the tidal volume. Therefore, the objective of this study is to measure and compare the tidal volume during the use of each device. Tidal volume will be measured using Electrical impedence tomography.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 19, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 26, 2018

Completed
3 days until next milestone

Study Start

First participant enrolled

March 1, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

March 2, 2018

Status Verified

February 1, 2018

Enrollment Period

1.3 years

First QC Date

February 19, 2018

Last Update Submit

February 28, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Tidal volume

    in milliliter

    Averaged value over the last 3 minutes of thoracic impedance recording

Secondary Outcomes (7)

  • pH

    After 15 minutes of using a non invasive oxygenation device

  • PaO2

    After 15 minutes of using a non invasive oxygenation device

  • PaCO2

    After 15 minutes of using a non invasive oxygenation device

  • Respiratory rate

    After 15 minutes of using a non invasive oxygenation device

  • Comfort

    After 15 minutes of using a non invasive oxygenation device

  • +2 more secondary outcomes

Study Arms (1)

De novo AHRF

Acute hypoxemic non hypercapnic respiratory failure with a PaO2/FiO2 ratio \< 200. The following oxygenation devices are used and assessed during routine care: High concentration mask, High flow nasal canula, NIV using buco-nasal mask or Helmet. Electro impedence tomography signal will be recorded throughout this assessement for tidal volume measurement

Device: Tidal volume measurement

Interventions

Recording of thoracic impendance variations during different non-invasive oxygenation techniques. Conversion to Tidal volume after calibration using the airway flow signal recorded during the NIV with bucco-nasal mask.

De novo AHRF

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with de novo acute hypoxemic respiratory failure

You may qualify if:

  • Respiratory rate \> 25 per minute
  • PaO2/FiO2 \< 200 mmHg
  • PaCO2 \< 45 mmHg
  • Signed consent by patient or relative

You may not qualify if:

  • Chronic respiratory disease
  • COPD exacerbation
  • Acute asthma
  • Cardiogenic pulmonary edema
  • Hemodynamic instability (systolic blood pressure \< 90 mmHg or mean blood pressure \< 65 mmHg or use of catecholamines)
  • Coma (Glasgow coma scale \< 12)
  • Contraindication to non-invasive ventilation
  • Indication to immediate intubation according to the physician

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Guillaume Carteaux, MD, PhD

    Henri Mondor University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Guillaume Carteaux, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 19, 2018

First Posted

February 26, 2018

Study Start

March 1, 2018

Primary Completion

June 30, 2019

Study Completion

September 1, 2019

Last Updated

March 2, 2018

Record last verified: 2018-02